Tradestie Institutional Equity Comparison Engine
BDRX vs SRTM โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
BDRX Overall Edge
BDRX Captures Institutional Edge (2โ0 Pillars ยท 6โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Biodexa Pharmaceuticals plc American Depositary Shs (BDRX) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, BDRX trades at N/M Forward P/E with 0.0% operating margin (-64.1% YoY revenue) versus SRTM at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, BDRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SRTM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
BDRX N/M vs SRTM N/M Fwd P/E
Growth & Margin Winner
BDRX
Op Margin 0.0% vs N/A ยท YoY -64.1% vs N/A
Momentum & Technical Winner
BDRX
1Y -51.4% vs -86.8% ยท 52W Pos 18% vs 2%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
BDRX
NASDAQ
Biodexa Pharmaceuticals plc American Depositary Shs
Pharmaceutical Preparations
$1.88
-6.02% 1D
Market Cap
$1.0M
1M Return
+352.9%
1Y Return
-51.42%
Forward P/E
N/M
Unified AI Score
36.0 / 100
SELL
Tech 15.0
Fund 36.0
Flow 50.0
Mom 50.0
SRTM
US Equity
SRTM
Institutional Equity
$0.08
-14.59% 1D
Market Cap
N/A
1M Return
-80.4%
1Y Return
-86.83%
Forward P/E
N/M
Unified AI Score
47.6 / 100
HOLD
Tech 50.0
Fund 50.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
BDRX -51.42%
SRTM -86.83%
Spread: +466.86 pp (BDRX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
BDRX TTM Op. Margin: 0.0%
SRTM TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BDRX vs SRTM. Trailing 12-month operating profitability (BDRX 0.0% vs SRTM N/A) and valuation multiples (BDRX N/M vs SRTM N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | BDRX | SRTM | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $1.0M | N/A | Larger Scale | BDRX |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -64.1% | N/A | Higher Growth | BDRX |
| Operating Margin (TTM) Profitability | 0.0% | N/A | Higher Margin | BDRX |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | BDRX |
| Return on Equity (ROE) Capital Efficiency | -42.0% | N/A | Higher ROE | BDRX |
| 52-Week Range Position Momentum | 18% ($0โ$9) | 2% ($0โ$1) | Stronger Trend | BDRX |
| Beta / 30D Volatility Risk Regime | 5.62ฮฒ ยท 2621% Vol | N/A | Lower Realized Risk | SRTM |
| Unified Institutional Score Composite Signal | 36.0 / 100 (SELL) | 47.6 / 100 (HOLD) | Higher Composite | SRTM |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full BDRX vs SRTM Buy Guide
BDRX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
SRTM
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither BDRX nor SRTM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.